Jnana Therapeutics Inc. — Form D
Jnana Therapeutics Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-16. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-16
- Form: D
- Accession: 0001567619-22-020461
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.0M
- Amount sold: $60.0M
- Investors: 8
- Date of first sale: 2022-11-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-465004
Issuer
- Name: Jnana Therapeutics Inc.
- CIK: 0001879148
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: One Design Center Place, BOSTON, MA, 02210
- Phone: (857) 349-9200
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Joel Stark Barrish | Executive Officer | Boston, MA |
| Annie C Chen | Director | Boston, MA |
| Douglas W Pagan | Executive Officer | Boston, MA |
| Ronald C Renaud, Jr. | Director | Boston, MA |
| George W Vratsanos | Executive Officer | Boston, MA |
| Carlo W Rizzuto | Director | Boston, MA |
| Terrance G McGuire | Director | Boston, MA |
| Joanne D Kotz | Director | Boston, MA |
| Joanne D Kotz | Executive Officer | Boston, MA |
| Donald W Nicholson | Director | Boston, MA |
| Caroline Stark Beer | Executive Officer | Boston, MA |
| Matthew W Hammond | Director | Boston, MA |
| Brian M Cali | Director | Boston, MA |
| Stuart W Schreiber | Director | Boston, MA |
| Kevin J Kinsella | Director | Boston, MA |
Other filings by this issuer (2)
More